News & Opinion
Healx CEO gives opening keynote at Orphan Drug Conference
Healx CEO, Tim Guilliams, will open the 5th Annual Orphan Drug Conference in London tomorrow, 19th October. This annual event brings together leading industry professionals to discuss the latest regulatory developments, explore how to reduce costs and learn from the latest innovations in the orphan drug landscape.
Discussing how Healx is building a patient centric model for rare disease drug discovery, he will specifically focus on the role of patient groups in drug discovery, applying artificial intelligence to drug repurposing and supporting non-for-profit drug discovery.